Home
About Us
Product Candidates
Patients
Press
Resources
Contact Us
Home
About Us
Product Candidates
Patients
Press
Resources
Contact Us
Login
Username
Password
Remember Me
Forgot your password?
Forgot your username?
Create an account
Press
April 19, 2010 - Interim Results of Phase I/II Clinical Trial Reported at 2010 AACR Annual Meeting
August 6, 2009 – Initiation of Phase I/II Clinical Trial
October 9, 2007 – Bellicum Announces $3.75 Million in Financing
October 11, 2006 - Commercial Licensing of ARIAD’s ARGENT™ Cell-Signaling Regulation Technology
Contact Us
Patient Information :
Regarding Patient Participation in Ongoing Clinical Trials
Contact (713) 341-6475
Investor Relations :
To Contact Bellicum Pharmaceuticals
Contact (713) 341-6472
If you would like to send us an email using your email application,
please
Click Here
Name or Company you are with :
Your Phone Number :
Your Email Address :
Reason you are contacting us :
Investor Relations
Product Information
Patient Information
Other Information
Other information you would like to provide us :
Send
